Key Takeaways & Executive Findings
- •• Transplanted cerebrospinal fluid-contacting neurons (CSF-cNs) survive long-term in vivo and differentiate into motor neurons in a mouse model of spinal cord injury. • CSF-cNs form synaptic connections with host neurons, as evidenced by co-expression of SYN, GAD65/67, and vGLUT1 at 8 weeks post-transplantation. • Transplantation of CSF-cNs significantly improves motor function recovery, with higher BMS scores and more coordinated gait compared to PBS control. • CSF-cNs reduce cavity formation at the injury site, indicating a neuroprotective and regenerative effect.
Abstract
BACKGROUND: Cell transplantation is one of the effective approaches for repairing spinal cord injury. Our research team previously found that transplanted cerebrospinal fluid-contacting neurons can survive and promote motor function recovery in mice with spinal cord injury. However, whether these transplanted cerebrospinal fluid-contacting neurons differentiate into functional neurons and thereby facilitate motor function recovery remains unclear. OBJECTIVE: To investigate whether transplanted cerebrospinal fluid-contacting neurons differentiate into functional neurons in vivo and contribute to motor function recovery after spinal cord injury. METHODS: Primary cells containing cerebrospinal fluid-contacting neurons were isolated from the cervical spinal cord of C57BL/6 neonatal mice within 24 hours of birth and cultured adherently. Cells were transduced with a lentivirus carrying a multimodal imaging gene, and cerebrospinal fluid-contacting neurons were selected and purified using puromycin. Differentiation was induced with serum-containing differentiation medium, and expression of neuronal marker NeuN and motor neuron marker ChAT was detected by immunofluorescence. Thirty C57BL/6 mice were randomly divided into three groups: transplantation group and PBS group underwent T10 spinal cord injury by clip compression, while sham group only had laminectomy. One week after injury, cerebrospinal fluid-contacting neurons were transplanted in situ in the transplantation group, and an equal volume of PBS was injected in the PBS group. At 1, 4, and 8 weeks after transplantation, immunofluorescence was used to detect expression of motor neuron marker ChAT in spinal cord tissue. At 8 weeks, immunofluorescence was used to detect synaptic marker SYN, inhibitory transmitter marker GAD65/67, and excitatory transmitter marker vGLUT1; hematoxylin-eosin staining was used to observe spinal cord morphology; BMS motor function score and footprint analysis were used to assess motor function recovery. RESULTS AND CONCLUSION: (1) Cerebrospinal fluid-contacting neurons expressed neural stem cell characteristics in vitro and could differentiate into motor neurons. (2) Transplanted cerebrospinal fluid-contacting neurons could survive long-term in vivo and differentiate into motor neurons. (3) The proportion of cerebrospinal fluid-contacting neurons differentiating into motor neurons was highest at 8 weeks (P < 0.0001). (4) At 8 weeks after transplantation, cerebrospinal fluid-contacting neurons co-expressed SYN, GAD65/67, and vGLUT1, indicating synaptic connections with host neurons. (5) BMS scores of PBS group were consistently lower than those of transplantation group (P < 0.001); footprint analysis showed more coordinated gait in transplantation group with only toe dragging, while PBS group showed obvious hindlimb dragging. (6) Hematoxylin-eosin staining showed large cavities in the injured area of PBS group, while cavities were reduced in transplantation group. These results indicate that transplanted cerebrospinal fluid-contacting neurons can differentiate into motor neurons both in vitro and in vivo, form synaptic connections, and thereby improve motor function in spinal cord-injured mice.
1. Introduction
Spinal cord injury (SCI) leads to severe motor, sensory, and autonomic dysfunction, and currently there is no effective treatment. Existing strategies, including surgical intervention and systematic rehabilitation, have limited efficacy in promoting neural regeneration and functional recovery. Over the past three decades, cell replacement therapy has shown promise in treating various neurological disorders. Neural stem cells, due to their potential for directed differentiation into neural tissues and good biocompatibility, are considered a promising avenue for SCI treatment. However, simple transplantation of neural stem cells faces issues such as insufficient integration, low survival rate, and limited differentiation efficiency. Therefore, selecting the appropriate type of neural stem cells for transplantation is crucial.
Cerebrospinal fluid-contacting neurons (CSF-cNs) are a type of multifunctional, multimodal cells located in the central nervous system, directly contacting the cerebrospinal fluid. They reside in neural stem cell niches in the spinal cord and possess mechanosensory functions, playing important roles in regulating posture and fine motor control in mammals. Recent studies have shown that CSF-cNs exhibit neural stem cell potential both in vivo and in vitro, and are a special neuronal population with endogenous neural stem cell properties, playing a key role in recovery after SCI. Using flow cytometry, adult endogenous CSF-cNs can form neurospheres in vitro and differentiate into neurons and glial cells. In previous research, we used lentivirus to label GFP-positive CSF-cNs and transplanted them into SCI mice; these cells survived under SCI conditions.
Loading authentic research manuscript (Pages 1–5)...
Tang Min, Shangguan Zeyu, Li Qizhe, Tan Wei, Li Qing (2026). Cerebrospinal fluid-contacting neurons differentiating into motor neurons promote functional recovery in spinal cord-injured mice. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21346
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What are cerebrospinal fluid-contacting neurons (CSF-cNs)?
CSF-cNs are a type of neuron located in the central nervous system that directly contact the cerebrospinal fluid. They are found in specific regions of the spinal cord and brainstem, and are present in neural stem cell niches. They have mechanosensory functions and exhibit neural stem cell properties, making them a potential cell source for transplantation therapy.
How were CSF-cNs isolated and cultured in this study?
CSF-cNs were isolated from the cervical spinal cord of C57BL/6 neonatal mice within 24 hours of birth. The primary cells were cultured adherently, transduced with a lentivirus carrying a multimodal imaging gene, and selected with puromycin to purify CSF-cNs. Differentiation was induced using serum-containing differentiation medium.
What were the main findings regarding differentiation of transplanted CSF-cNs?
Transplanted CSF-cNs survived long-term in vivo and differentiated into motor neurons, as indicated by expression of ChAT. The proportion of differentiation into motor neurons was highest at 8 weeks post-transplantation. Additionally, they formed synaptic connections with host neurons, evidenced by co-expression of SYN, GAD65/67, and vGLUT1.
How did CSF-cN transplantation affect motor function recovery in SCI mice?
Mice receiving CSF-cN transplantation showed significantly improved motor function compared to PBS controls, with higher BMS scores and more coordinated gait. Histological analysis revealed reduced cavity formation at the injury site, suggesting neuroprotective and regenerative effects.
What is the potential clinical significance of this study?
This study provides evidence that CSF-cNs can differentiate into functional motor neurons and form synaptic connections, leading to improved motor function after SCI. This suggests that CSF-cNs could be a promising cell source for cell replacement therapy in spinal cord injury and other neurological disorders.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.